Nitrogen containing substituted heterocycles as platelet ADP receptor inhibitors

Details for Australian Patent Application No. 2007299723 (hide)

Owner Portola Pharmaceuticals, Inc.

Inventors Scarborough, Robert M.; Pandey, Anjali; Bauer, Shawn M.

Agent Davies Collison Cave

Pub. Number AU-A-2007299723

PCT Pub. Number WO2008/036843

Priority 11/856,616 17.09.07 US; 60/846,328 20.09.06 US

Filing date 20 September 2007

Wipo publication date 27 March 2008

International Classifications

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/536 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

C07D 239/96 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 265/22 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

23 April 2009 PCT application entered the National Phase

  PCT publication WO2008/036843 Priority application(s): WO2008/036843

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007299726-Combination comprising an HMG-COA reductase inhibitor and a second neurogenic agent for treating a nervous system disorder and increasing neurogenesis

2007299719-Grain angle sensor